The US Food & Drug Administration’s Oncology Center of Excellence is preparing an alternative approach to briefing documents for an upcoming advisory committee meeting intended to highlight key points of disagreement between the agency and the sponsor.
OCE Director Richard Pazdur announced the pilot almost offhand during remarks to the Friends of Cancer Research annual meeting on 12 November. At the time, Pazdur was providing an update on the OCE’s most recently unveiled pilot, the “Project Orbis” joint review program
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?